Insider sale
TENAYA THERAPEUTICS, INC.
$2.30M
3.48M shares
What this filing means
COLUMN GROUP III, LP plans to sell 3.48M shares of TENAYA THERAPEUTICS, INC. valued at approximately $2.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/20/2026ACC: 0001178937-26-000009
10% Owner
Since Jul 2021
3.48M
Shares to sell
$2.30M
Approx. market value
1.41M
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Series A financing
Cash
12/20/2018
1.21MSeries A financing
Cash
7/31/2017
200.03KTotal acquired1.41M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/20/2018 | Series A financing Cash | 1.21M | — |
7/31/2017 | Series A financing Cash | 200.03K | — |
| Total | 1.41M | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.91M
Market value
$1.30M
2/11/2026
—Completed
Units to sell
161.42K
Market value
$131.7K
2/10/2026
Planned — Approximate Date
NASDAQ GSPlanned
Units to sell
1.41M
Market value
$872.5K
2/20/2026
Total
Units
3.48M
Value
$2.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2026 | 1.91M | $1.30M | — | Completed |
2/10/2026 | 161.42K | $131.7K | — | Completed |
| Planned — Approximate Date | ||||
2/20/2026 | 1.41M | $872.5K | NASDAQ GS | Planned |
| Total | 3.48M | $2.30M | ||